How should healthcare organisations design IAM for interoperability across EHRs, APIs, partners, and connected medical devices?

Design IAM as the interoperability control plane

For healthcare interoperability, IAM should be treated as the control plane that decides who or what can exchange clinical data, under which conditions, and with what auditability. That means separating the interoperability layer from the trust layer: EHR integration, API access, partner exchange, and connected device access should all be mediated by policy, not by ad hoc trust between systems.

In practice, the architecture should support federated identity where appropriate, but avoid assuming that federation alone is enough. The more partners and channels you have, the more important it becomes to standardise identity proofing, token issuance, session scope, and revocation so access can be changed without breaking the exchange fabric.

connected medical device need the same discipline, but with tighter constraints on onboarding, attestation, and lifecycle control. The device should not be trusted just because it is on the network; its identity, firmware state, and allowed data flows should be explicit parts of the interoperability design.

What to standardise across EHRs, APIs, partners, and devices

The most useful design choice is to define common access patterns rather than one-off integrations. That usually means a small set of approved authentication methods, token types, scopes, and policy decisions that every integration must use, even if the implementation differs by channel.

For EHR and partner integrations, OWASP API Security Top 10 is a useful reference point because broken authorisation and unsafe consumption are common failure modes when systems exchange clinical data through APIs. For cloud and partner trust boundaries, CSA Cloud Controls Matrix helps map IAM, data handling, and governance expectations across external environments.

Where the interoperability model includes devices, the identity requirements must extend beyond users to workload and device credentials. A practical healthcare pattern is to combine short-lived credentials, strong device identity, and explicit data-use scopes so a device can receive only the minimum access needed for its clinical function.

For connected device trust, Device and IoT Identity Guide is directly relevant because it covers device certificates, attestation, onboarding, and lifecycle control. For broader machine and workload access, Cloud Workload Identity Guide supports the shift away from static keys and toward federated, short-lived, and auditable credentials.

Governance choices that keep interoperability secure over time

Healthcare IAM fails most often when interoperability is treated as a project rather than an operating model. The organisation needs a clear decision framework for who owns each integration, who approves trust relationships, how access is reviewed, and how exceptions are retired when a partner or device is decommissioned.

That governance layer must include credential lifecycle management, because clinical interoperability often accumulates stale access, service accounts, API keys, and partner tokens over time. NHI Lifecycle Management Guide is relevant here because the same lifecycle problems that affect service identities in other sectors also affect healthcare integrations, especially where vendors, labs, imaging systems, and remote monitoring platforms exchange data continuously.

Healthcare organisations should also distinguish between interoperability that is patient-initiated, clinician-initiated, and system-to-system. Those flows often need different authentication strength, session duration, consent handling, and emergency access rules, even when they touch the same records.

Risk and Threat Considerations

Interoperability expands the blast radius of a single weak identity decision. If an EHR integration, partner token, or device credential is overprivileged, compromised, or left active after a relationship ends, the attacker may inherit legitimate access to clinical data and trusted workflows rather than needing to break the clinical system itself.

Failure mechanism: Weak federation, long-lived secrets, excessive scopes, or poor offboarding lets one trusted integration become a reusable access path across many systems, which is especially dangerous when APIs and devices are allowed to call the same data services.

Impact: Data exposure, fraudulent transactions, disrupted clinical workflows, and harder-to-detect lateral movement through trusted healthcare channels can follow, with patient safety and regulatory consequences if access cannot be rapidly contained.

Practitioner Guidance

What to prioritise: Start by defining the trust model for each interoperability class: human users, clinical applications, partner systems, and connected devices should not share the same authentication and authorisation assumptions. If you cannot describe the access boundary in one sentence, the integration is probably too permissive.

What to verify: Confirm that every external relationship has an owner, an expiry or review point, and a revocation path that works without emergency manual workarounds. Also verify that logs can answer who accessed what, on behalf of whom, and through which integration.

Practitioner takeaway: The safest interoperability designs are the ones that make trust explicit, time-bound, and observable, because healthcare integration becomes fragile the moment access is implicit or permanent.

Related resources from NHI Mgmt Group

• How should healthcare organisations reduce breach risk across EHRs, connected medical devices, and third-party access?
• How should healthcare organisations govern identity access as EHRs, telehealth, and medical devices expand at the same time?
• How should healthcare security teams use pentesting to reduce ransomware risk across connected systems and medical devices?
• How should healthcare organisations use digital certificates to secure connected medical devices?